Alcon Research

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Alcon Research sits in the top decile of US sponsors by registered trial count (#124 of 15,742 sponsors by registered trial count).

275 total trials 5 currently recruiting 248 completed later-stage tilt top decile by trial count

Alcon Research: 275 sponsored US clinical trials, 5 recruiting.

Alcon Research sponsors 275 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 248 completed. 87 of these trials are in Phase 3-4 (later-stage) and 28 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataract, with 12 trials.

Top-decile sponsor footprint

Alcon Research ranks in the top decile of sponsors by registered trial count (#124 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 73/100

248 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

275 total, page 2 of 6

COMPLETED NA

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

NCT05338333

COMPLETED NA

Clinical Assessment of a Daily Wear Monthly Replacement Silicone Hydrogel Toric Contact Lens

NCT05211739

COMPLETED NA

Clinical Performance of Two Daily Disposable Soft Contact Lenses

NCT05138783

TERMINATED NA

Safety and Effectiveness of the Hydrus Microstent

NCT05198297

COMPLETED NA

Systane Complete Multi-symptom Relief

NCT05056155

COMPLETED NA

Clinical Assessment of Two Reusable Silicone Hydrogel Contact Lenses

NCT05050578

COMPLETED NA

Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses

NCT05039112

COMPLETED NA

Clinical Performance of Two Commercial, Daily Disposable Contact Lenses

NCT05010512

COMPLETED NA

Clinical Assessment of Two Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lenses

NCT04980456

COMPLETED NA

Clinical Comparison of Two Daily Disposable Contact Lenses - Pilot Study 3

NCT04942925

COMPLETED NA

Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses

NCT04908488

COMPLETED NA

Clinical Comparison of Two Daily Disposable Contact Lenses

NCT04865354

COMPLETED NA

Clinical Investigation of the WaveLight® EX500 Excimer Laser

NCT04805593

COMPLETED NA

Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations

NCT04789382

COMPLETED NA

Clinical Characterization of an Investigational Frequent Replacement Daily Wear Silicone Hydrogel Sphere Contact Lens

NCT04702984

COMPLETED NA

Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent

NCT04629521

COMPLETED NA

Clinical Characterization of an Investigational Soft Silicone Hydrogel Contact Lens

NCT04631796

COMPLETED NA

Clinical Evaluation of a Silicone Hydrogel Daily Wear Monthly Replacement Contact Lens

NCT04422990

COMPLETED NA

Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1

NCT04527978

COMPLETED NA

Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses

NCT04532099

COMPLETED NA

Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 2

NCT04528017

COMPLETED NA

Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens

NCT04476784

COMPLETED NA

Pilot Clinical Performance of a Silicone Hydrogel Lens for Up to Six Nights of Extended Wear

NCT04403542

COMPLETED NA

Clinical Performance of a Daily Disposable Toric Silicone Hydrogel Contact Lens

NCT04464044

COMPLETED NA

WaveLight® EX500 Excimer Laser System for the Correction of Myopia Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap

NCT04219891

COMPLETED NA

Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses

NCT04254003

COMPLETED NA

Clinical Evaluation of a Daily Wear Monthly Replacement Silicone Hydrogel Lens

NCT04178720

COMPLETED NA

Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens

NCT04207749

COMPLETED NA

Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens

NCT04085328

COMPLETED NA

Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens

NCT04055519

COMPLETED NA

Comparison of Two Daily Disposable Lenses

NCT04013789

COMPLETED NA

Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study

NCT03956225

COMPLETED NA

Clinical Evaluation of a Daily Wear Frequent Replacement Silicone Hydrogel Lens

NCT03920280

COMPLETED NA

Clinical Comparison of DDT2 Contact Lens and a Daily Disposable Contact Lens - Study 1

NCT03888469

COMPLETED NA

Clinical Comparison of DDT2 Contact Lens and a Daily Disposable Contact Lens - Study 2

NCT03888482

TERMINATED NA

Multifocal Visual Performance Study

NCT03757039

COMPLETED NA

Performance Assessment of a Modified Daily Disposable Contact Lens

NCT03762668

COMPLETED NA

Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs

NCT03733730

COMPLETED NA

Clinical Performance of a Silicone Hydrogel Contact Lens Following Six Nights of Extended Wear

NCT03614130

COMPLETED NA

Postmarket Study of an Intraocular Lens Power Selection System

NCT03579433

COMPLETED NA

Two Daily Disposable Contact Lenses in Symptomatic Patients

NCT03628599

COMPLETED NA

Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens

NCT03586167

COMPLETED NA

Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease

NCT03492541

COMPLETED NA

Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear

NCT03560141

COMPLETED NA

Clinical Validation of DACP Digital Design

NCT03567005

COMPLETED NA

Clinical Comparison of Two Daily Disposable Soft Contact Lenses

NCT03518008

COMPLETED NA

Clinical Evaluation of Two Monthly Contact Lenses

NCT03459131

COMPLETED NA

Clinical Comparison of 4 Daily Disposable Soft Contact Lenses

NCT03349632

COMPLETED NA

Comparison of Two Silicone Hydrogel Toric Contact Lenses

NCT03392532

COMPLETED NA

Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00

NCT03280108

← Previous Page 2 of 6 Next →

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 23
Phase 3 47
Phase 4 40

Where Alcon Research enrollment is open (later-stage tilt)

5 recruiting of 275 indexed (2% open); 248 completed (90%).

Phase mix: 87 late (III/IV) vs 28 early (I/II) (later-stage heavy).

Top condition: Cataract (12 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Alcon Research: open-pipeline peers nationwide

Peers matched on 275 registered trials and 2% open enrollment, not the therapeutic-area sidebar.

Alcon Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300 0%5%10%15%20%25% Total trials Recruiting share Alcon ResearchBoston Scientific CorporationRegeneron PharmaceuticalsSWOG Cancer Research NetworkNovartisLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterLexicon PharmaceuticalsSociété des Produits Nestlé (SPN)Eisai
Alcon Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Alcon Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 275 trials (± recruiting share)

Sponsors near 2% open enrollment (± trial volume)

What to do with this Alcon Research page

275 registered trials is a research-attention snapshot, not an endorsement of Alcon Research or any single study.

  • 5 of Alcon Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cataract is the condition Alcon Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataract trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Alcon Research pipeline card: 275 registered trials from official public datasets.Report a data error.